Early glottic cancer treatment with concurrent chemoradiotherapy with once-daily orally administered S-1

Glottic carcinoma is the most common laryngeal cancer. The outcomes for T1 bulky Glottic carcinoma and T2N0 Glottic carcinoma after radiation therapy alone are unsatisfactory. This study was conducted to evaluate the efficacy and safety of unique concurrent chemoradiotherapy regimen using S-1 for ea...

Full description

Saved in:
Bibliographic Details
Published in:Nagoya J Med Sci
Main Authors: Takase, Yuuki, Itoh, Yoshiyuki, Ohtakara, Kazuhiro, Kawamura, Mariko, Ito, Junji, Oie, Yumi, Ono, Tamami, Sasaki, Yutaro, Nishida, Ayumi, Naganawa, Shinji
Format: Artigo
Language:Inglês
Published: Nagoya University 2021
Subjects:
Original Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8236680/
https://ncbi.nlm.nih.gov/pubmed/34239173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18999/nagjms.83.2.251
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items